The Global Antibiotics Active Pharmaceutical Ingredient Industry is poised for an extraordinary leap, with a projected value of US$ 8,653.0 million in 2023 and an anticipated expansion to a staggering US$ 12,002.3 million by 2033. This remarkable trajectory is fuelled by a steadfast Compound Annual Growth Rate (CAGR) of 3.3% throughout the forecast period, as …